Advanced Therapies 2026

About the event

Advanced Therapies 2026 is Europe’s largest commercial cell and gene therapy conference and exhibition. For over 10 years, this event has been a pivotal gathering for industry leaders, showcasing the latest advancements and strategies in the field.

Attendees can expect a vibrant atmosphere with over 3,300 professionals, 300 speakers, and 200 exhibitors, all dedicated to advancing the field of advanced therapies. The event promises a wealth of knowledge and networking opportunities that are crucial for anyone involved in the sector.

This congress not only features a comprehensive agenda covering various topics but also includes special presentations from emerging biotech start-ups, making it a unique platform for innovation and collaboration.

---

Keynote speakers and expert panels

Roy Baynes (USA/Eikon Therapeutics) - “Advancements in Gene Therapy”
Dame Molly Stevens (UK/University of Oxford) - “Innovations in Cell Therapy”
Bobby Gaspar (UK/Orchard Therapeutics) - “Challenges in Clinical Adoption”

Over 8 sessions covering critical topics, with CPD/continuing education credits available.

---

Special features

• Innovation Awards recognizing outstanding contributions in the field.
• Dedicated networking sessions designed to foster collaboration among attendees.
• Company presentations from exciting new start-ups, providing insights into the latest innovations.

---

Featured exhibitors and innovations

• Eikon Therapeutics will be showcasing their latest advancements in gene therapy.
• Orchard Therapeutics is launching a new product aimed at improving patient outcomes.
• Autolus will present their innovative CAR-T therapies.